Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative cimetidine versus placebo in resectable colorectal cancer
ACTRN12609000769280Phase 2Active, not recruiting
- Sponsor
- Waikato Hospital
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in colorectal cancer (CRC) comparing Cimetidine with Placebo (2 arms). Primary endpoint: 2-year disease-free survival in subgroup with positive tumor immunostaining for sialyl Lewis a or x. Started Mar 2010; status: active, not recruiting.
02
Drugs
cimetidine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ACTRN12609000769280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000769280.